Practice
Featured experience
Emerson $7.2 billion acquisition of remaining outstanding shares of AspenTech
We are advising Emerson on its acquisition
Intra-Cellular Therapies $14.6 billion acquisition by Johnson & Johnson
We are advising Intra-Cellular Therapies on the transaction
GSK up to $1.15 billion acquisition of IDRx
We are advising GSK on the transaction
Royalty Pharma $1.1 billion acquisition of its external manager and $3 billion share repurchase
We are advising Royalty Pharma on the transaction
Everfox acquisition of Garrison Technology
We are advising Everfox on the acquisition
Harbour Energy $11.2 billion acquisition of Wintershall Dea upstream assets
We are advising Barclays Bank as sponsor to Harbour Energy on the transaction
Red Bull minority investment in and sponsorship of Leeds United Football Club
We advised Red Bull on its investment in 49ers Enterprises Global Football Group and sponsorship of Leeds United
Emerson $3.5 billion sale of remaining interests in Copeland to Blackstone
We are advising Emerson on the sale
BlackRock minority investment in TXSE Group
We are advising BlackRock on the transaction
$100 million investment by consortium in Airbus subsidiary AALTO
We are advising Airbus on the transaction
Asplundh Tree Expert acquisition of Voltyx Energy Solutions
We are advising Asplundh Tree Expert on the acquisition
Asahi Kasei $1.1 billion offer to acquire Calliditas Therapeutics
We are advising Lazard as financial adviser to Calliditas on the transaction
Nordson $800 million acquisition of Atrion
We are advising Nordson on the acquisition
GHK $520 million sale of Supreme Cabinetry Brands to MasterBrand
We are advising GHK Capital Partners and Supreme Cabinetry Brands on the transaction